About ispecimen inc - ISPC
iSpecimen, Inc. is a healthcare organization that engages in procurement of human biospecimen. It collects biofluids, human tissue, hematopoietic stem, and immune cells. The company was founded by Christopher Ianelli in 2009 and is headquartered in Woburn, MA.
ISPC At a Glance
iSpecimen, Inc.
8 Cabot Road
Woburn, Massachusetts 01801
| Phone | 1-781-301-6700 | Revenue | 1.93M | |
| Industry | Miscellaneous Commercial Services | Net Income | -10,487,532.00 | |
| Sector | Commercial Services | Employees | 7 | |
| Fiscal Year-end | 12 / 2026 | |||
| View SEC Filings |
ISPC Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 0.621 |
| Price to Book Ratio | 0.714 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | 1.007 |
| Enterprise Value to Sales | -2.807 |
| Total Debt to Enterprise Value | -0.05 |
ISPC Efficiency
| Revenue/Employee | 275,571.143 |
| Income Per Employee | -1,498,218.857 |
| Receivables Turnover | 39.94 |
| Total Asset Turnover | 0.204 |
ISPC Liquidity
| Current Ratio | 1.116 |
| Quick Ratio | 1.116 |
| Cash Ratio | 1.104 |
ISPC Profitability
| Gross Margin | -78.55 |
| Operating Margin | -368.422 |
| Pretax Margin | -543.678 |
| Net Margin | -543.678 |
| Return on Assets | -111.087 |
| Return on Equity | -327.774 |
| Return on Total Capital | -312.405 |
| Return on Invested Capital | -304.874 |
ISPC Capital Structure
| Total Debt to Total Equity | 8.704 |
| Total Debt to Total Capital | 8.007 |
| Total Debt to Total Assets | 2.82 |
| Long-Term Debt to Equity | 6.861 |
| Long-Term Debt to Total Capital | 6.311 |